These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6803172)

  • 21. T lymphocytes of young and aged rats. II. Functional defects and the role of interleukin-2.
    Gilman SC; Rosenberg JS; Feldman JD
    J Immunol; 1982 Feb; 128(2):644-50. PubMed ID: 6459382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo activation of macrophages by T cell-derived lymphokines: killing of tumor cells and schistosomula of Schistosoma mansoni.
    Kubelka CF; Ruppel A; Gemsa D; Krammer PH
    Immunobiology; 1986 Jul; 171(4-5):311-9. PubMed ID: 3091486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
    Chang JC; Zhang L; Edgerton TL; Kaplan AM
    J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protein and polypeptide growth factors--T lymphocyte growth factor and interleukins].
    Suzuki R; Kumagai K
    Nihon Rinsho; 1986 Jan; 44(1):42-7. PubMed ID: 2421027
    [No Abstract]   [Full Text] [Related]  

  • 25. Third French Workshop on interleukin 2: joint report.
    Jacques Y; Soulillou JP
    Lymphokine Res; 1985; 4(2):159-67. PubMed ID: 3873589
    [No Abstract]   [Full Text] [Related]  

  • 26. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
    Farrar WL; Mizel SB; Farrar JJ
    J Immunol; 1980 Mar; 124(3):1371-7. PubMed ID: 6153680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphokine production using IL-2-dependent human T-lymphocytes].
    Stecher A; Mohr H; Schügerl K
    Beitr Infusionther Klin Ernahr; 1987; 18():292-4. PubMed ID: 3125831
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of cytotoxic T cell function requires sequential action of three different lymphokines.
    Männel DN; Falk W; Dröge W
    J Immunol; 1983 Jun; 130(6):2508-10. PubMed ID: 6602167
    [No Abstract]   [Full Text] [Related]  

  • 29. T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function.
    Kramer M; Koszinowski U
    J Immunol; 1982 Feb; 128(2):784-90. PubMed ID: 6459386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice.
    Wagner H; Hardt C; Heeg K; Röllinghoff M; Pfizenmaier K
    Nature; 1980 Mar; 284(5753):278-8. PubMed ID: 6965769
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 32. Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant.
    Ely JM; Prystowsky MB; Eisenberg L; Quintans J; Goldwasser E; Glasebrook AL; Fitch FW
    J Immunol; 1981 Dec; 127(6):2345-9. PubMed ID: 6975317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intercellular communication: role of soluble factors in cellular immune responses.
    Klesius PH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1015-21. PubMed ID: 6816771
    [No Abstract]   [Full Text] [Related]  

  • 34. A suggested mechanism for T lymphocyte activation: implications on the acquisition of functional reactivities.
    Larsson EL; Coutinho A; Martinez C
    Immunol Rev; 1980; 51():61-91. PubMed ID: 6159302
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of interleukins 1 and 2 on human thymocyte mitogen activation.
    Piantelli M; Lauriola L; Maggiano N; Ranelletti FO; Musiani P
    Cell Immunol; 1981 Nov; 64(2):337-49. PubMed ID: 6796273
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.
    Farrar WL; Johnson HM; Farrar JJ
    J Immunol; 1981 Mar; 126(3):1120-5. PubMed ID: 6161959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 2 activates BB/W diabetic rat lymphoid cells cytotoxic to islet cells.
    Pukel C; Baquerizo H; Rabinovitch A
    Diabetes; 1987 Nov; 36(11):1217-22. PubMed ID: 3311852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.
    Luger TA; Smolen JS; Chused TM; Steinberg AD; Oppenheim JJ
    J Clin Invest; 1982 Aug; 70(2):470-3. PubMed ID: 6808028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA; Piguet PF; Vassalli P
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.
    Altman A; Theofilopoulos AN; Weiner R; Katz DH; Dixon FJ
    J Exp Med; 1981 Sep; 154(3):791-808. PubMed ID: 6456321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.